Metabolic engineering for the production of isoprene and isopentenol by Escherichia coli
The biotechnological production of isoprene and isopentenol has recently been studied. Isoprene, which is currently made mainly from petroleum, is an important platform chemical for synthesizing pesticides, medicines, oil additives, fragrances, and more and is especially important in the rubber production industry. Isopentenols, which have better combustion properties than well-known biofuels (ethanol), have recently received more attention. Supplies of petroleum, the conventional source of isoprene and isopentenols, are unsustainable, and chemical synthesis processes could cause serious environmental problems. As an alternative, the biosynthesis of isoprene and isopentenols in cell factories is more sustainable and environmentally friendly. With a number of advantages over other microorganisms, Escherichia coli is considered to be a powerful workhorse organism for producing these compounds. This review will highlight the recent advances in metabolic engineering for isoprene and isopentenol production, especially using E. coli cell factories.
KeywordsIsoprene Isopentenol MVA MEP Metabolic engineering
Isoprenoids comprise a large variety of natural products varying in structure and function, many of which are important chemicals, such as flavors, fragrances, pigments, antioxidants, steroids, and drugs (Sacchettini and Poulter 1997). Isoprenoids are classified according to their number of five-carbon units, which are their basic building blocks (Ruzicka 1953). Hemiterpenoids consist of one unit and include isoprene, isopentenols (prenol and isoprenol), and other chemicals. All isoprenoids are derived from the universal C5 prenyl phosphate precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), which are supplied by the methylerythritol phosphate (MEP) pathway or the mevalonate (MVA) pathway. Then, downstream steps utilize IPP and DMAPP to produce a number of isoprenoids (Klein-Marcuschamer et al. 2007).
In the synthetic chemistry industry, isoprene (C5H8) can be used as a platform chemical for a variety of products, such as rubbers, adhesives, elastomers, pesticides, medicines, oil additives, fragrances, and biofuels (Claeys et al. 2004; Ruzicka 1953). Approximately 95% of isoprene is used for rubber synthesis, and approximately 20 million tons of rubber is produced annually (Yang et al. 2012b). Currently, isoprene is produced industrially from cracking petroleum, an unrecoverable and environment-unfriendly resource (Whited et al. 2010). Isoprene collection from plants is another production method. Isoprene is naturally produced by many plants and is emitted into the earth’s atmosphere in teragram quantities (Grawert et al. 2004; Sharkey et al. 2008; Sharkey and Yeh 2001). However, its volatility makes this collection difficult. Moreover, plant cultivation is seasonally dependent and requires land resources, which hinders large-scale production (Gupta and Phulara 2015; Vickers et al. 2014). There is a major need for sustainable industrial isoprene production methods. Metabolic engineering of microbial systems for isoprene production might be a feasible alternative to address these problems. The well-studied microbial host Escherichia coli has been mostly used for the bio-production of isoprene with heterologous MVA pathway introduction or endogenous MEP pathway modification and isoprene synthase (IspS) introduction (Klein-Marcuschamer et al. 2007; Martin et al. 2003).
Isopentenols, including isoprenol and prenol, currently obtained from petroleum-based isobutene and formaldehyde, have recently received attention as advanced biofuels. These biofuels show some attractive characteristics, such as higher energy density, higher octane numbers, lower water miscibility, and better low-temperature fluidity than other biofuels (Gupta and Phulara 2015). These combustion properties make isopentenols a potential substitute for petroleum. Notably, isopentenols have significant knock resistance and can improve the anti-knock properties of petroleum as additives (Mack et al. 2014). As isoprenoids, isopentenols can also be obtained from the common precursors IPP and DMAPP, which are dephosphorylated by phosphatase. Similar to isoprene, metabolic engineering of cell factories to improve isopentenol production has been applied.
Furthermore, the metabolic engineering of cell factories for isoprene and isopentenol production is also instructive and meaningful for engineering the bio-production of other isoprenoids. To some extent, the MEP and MVA pathways are shared by all isoprenoids, and metabolic engineering methods for the biosynthesis of isoprenoids are mutually referential. However, metabolic engineering of the pathway into naive microbial hosts can result in the accumulation of IPP and DMAPP, which are toxic for bacterial growth (George et al. 2018). Therefore, balancing the accumulation and consumption of IPP and DMAPP is very important for isoprenoid bio-production (Klein-Marcuschamer et al. 2007). Unlike other isoprenoids, isoprene and isopentenol are direct derivatives of IPP and DMAPP, which makes controlling the accumulation of IPP and DMAPP easier than other isoprenoids. Therefore, engineering methods for isoprene and isopentenol production are likely easier than engineering methods for other isoprenoids, although they are still generally instructive, especially for methods related to the balance of the IPP/DMAPP pool.
Bio-isoprene production and related research progress have been previously summarized in several reviews. The material and energy efficiencies, cost and economic evaluation of chemical- and biological-based isoprene production were estimated and compared by Morais et al. in 2015 (Morais et al. 2015). Isoprene production methods using petrochemical and biological sources were first described by Genencor in 2010, in a summary of their patents (Whited et al. 2010). Engineering of isoprene production in microbes was simply described as a case study in a review on isoprenoid production in 2014 and 2015 (Vickers et al. 2014; Whited et al. 2010; Ye et al. 2016). In the latest review, bio-isoprene production in different cell factories was reviewed (Ye et al. 2016). Thirteen articles on bio-isoprene production have been published in the last 2 years, representing almost half of the total published studies concerning isoprene bio-production since 2001. Novel engineering approaches have been applied and great improvements in isoprene production have been achieved, especially in the E. coli cell factories, which are considered as a powerful workhorse organism for producing a wide range of biofuels and chemicals and have garnered more attention. In addition, the bio-production of isopentenol has not been reviewed.
In this review, we summarize the biotechnological production of isoprene and isopentenol, especially in E. coli cell factories. Five sections are divided according to the target of the engineering approach: IspS for isoprene production, phosphatase for isopentenol production, the natural MEP pathway, the heterogeneous MVA pathway, and precursor support. The key enzymes and applied engineering approaches in E. coli are described. Challenges and prospects for future engineering are also discussed in this review.
Use of IspS for isoprene production
Even though the MEP pathway is naturally expressed in E. coli, no IspS has been identified. To improve isoprene production in E. coli, the introduction of IspS is required. In plants, IspS has been proven to be the limiting enzyme in the MEP pathway, which is related to the effect of isoprene release in plants, as it has a protective effect against environmental stresses (Sharkey et al. 2008). Isoprene is an aeriform product, unlike most other organic products, and feedback inhibition is avoided through this pathway. These qualities make IspS the bottleneck for isoprene production. Moreover, enzyme assays have indicated that most studied IspS enzymes have low activity and low affinity for the substrate DMAPP, as indicated by low kcat values and high Km values in the millimolar range (Schnitzler et al. 2005). IspS is essential for the industrial-scale production of isoprene. Research on IspS has focused mainly on improving the activity and efficiency of the enzyme, including screening new IspS enzymes and performing directed evolution and other metabolic engineering strategies.
Screening of IspS
Summary of the IspS enzymes utilized for isoprene production
Number of studies
Km = 8.7/15.9 mM
kcat = 0.03/0.034 s−1
P. montana (kudzu)
Km = 7.7/2.5 mM
kcat = 0.088/4.4 s−1
Yang et al. 2012b
Km = 0.2 mM
kcat = 0.195 s−1
Gao et al. 2016
Ilmen et al. 2015
Kim et al. 2016
IspS enzymes have been identified in several plants since the first IspS was cloned from gray poplar in 2001. Moreover, while isoprene has been successfully detected in microbes, such as Bacillus subtilis, no IspS-encoding gene has yet been identified in microorganisms (Julsing et al. 2007; Sivy et al. 2002). IspS enzymes in different species show similarities in characteristic indexes. Most IspS enzymes show optimal enzyme activity at temperatures of 40–45 °C, with some exceptions at 35 and 50 °C (Lehning et al. 1999; Schnitzler et al. 1996). IspS from plants has an optimum pH between 7 and 10, preferring alkaline conditions, similar to other enzymes with botanical origins (Oku et al. 2015). IspS shows relatively high Km values for DMAPP (in the millimolar range) and low kcat values (in the range of 0.011–1.7 s−1) (Table 1), which indicate that high concentrations of DMAPP are required and low levels of isoprene are produced. Of note, the temperature and pH preferences of IspS are not consistent with E. coli culture conditions. During fermentation, IspS shows low enzyme activity, and the metabolic flux for isoprene production is seriously hampered at this point. For bio-isoprene production, especially in E. coli, screening IspS enzymes for appropriate biochemical properties for expression in microbes is still a promising approach.
Directed evolution of IspS
Based on the information provided by the three-dimensional structure, several amino acid mutations were applied, resulting in increased enzyme activity (Fig. 2). In white poplar, mutation of amino acid L494 led to an approximately 2-fold increase in enzyme activity (Beck et al. 2013a). Interestingly, IspSs from other organisms commonly contain residue P in the homologous site (Fig. 2). For gray poplar, the K272R mutation shows a 1.8- to 2-fold increase in activity relative to wild type (Bott et al. 2014). Except for IspS from gray poplar, an R residue is located in the same position (Fig. 2). Three positive mutations, F340L, I478V, and A570T, were identified in white poplar, and mutated amino acids revealed essential roles in enzyme activity (Wang et al. 2017). In the homologous F340 site, amino acid L is adopted in IspSs from three other species, I. batatas, P. montana, and E. globulus, and the utilization of these IspSs resulted in improved bio-isoprene production (Table 1 and Fig. 2). Similarly, residue V present in the homologous I478 site in IspSs was speculated to have better enzyme activity (Table 1 and Fig. 2). Mutation information on IspS is not only helpful for understanding the enzyme structure but is also instructive for enzyme engineering of IspSs for bio-isoprene production in microbes. In a recent study, directed evolution of IspS from white poplar was performed, and a 3-fold increase in isoprene production was obtained (Wang et al. 2017).
Other metabolic engineering strategies for IspSs in E. coli
For isoprene production in E. coli, a plant-derived IspS is heterogeneously expressed, and metabolic engineering methods are applied to improve enzyme expression and activity. First, codon optimization and removal of the chloroplast-targeting peptide were utilized (Lindberg et al. 2010; Yang et al. 2012b). A 1-fold increase in isoprene production was achieved by deleting the 5′ part of the IspS sequence from gray poplar (Miller et al. 2001). Finding the appropriate expression vector was another essential process. For IspS from kudzu, among the tested vectors, the low copy vector, pCL1920, produced more isoprene than other vectors (Cervin et al. 2012). Improving enzyme activity is another powerful strategy. In recent studies, as a rate-limiting enzyme with high Km value, IspS was fused with IDI to improve the interaction between the substrate DMAPP and IspS (Bentley and Melis 2012; Bentley et al. 2014; Lindberg et al. 2010). In another study, interestingly, the introduction of monoterpene or sesquiterpene synthase, which consumes excessive DMAPP, into an engineered strain resulted in increased isoprene production (Chotani et al. 2013).
However, even though IspSs from different plant species have been utilized, and several engineering methods have been applied in the last 15 years, the production of isoprene from DMAPP is still seriously hampered. Directed evolution of IspS is still a challenge, and high-throughput screening is difficult, as isoprene is a volatile gas, and the substrate, DMAPP, is not easy to monitor. A screening method based on the cytotoxicity of DMAPP was constructed (Wang et al. 2017). In the near future, identifying IspSs from other organisms with better activity and establishing more stable high-throughput screening methods may offer powerful breakthroughs.
Use of phosphatase for isopentenol production
Modification of the natural MEP pathway in E. coli
The MEP pathway exists in E. coli naturally, and this pathway has been modified. Engineered E. coli in which only IspS was introduced showed low levels of isoprene production (Miller et al. 2001). Promoting flux through core isoprenoid pathways has been shown to be the most powerful way to increase isoprene and isopentenol production in E. coli.
Description of the MEP pathway
Rohmer et al. demonstrated the existence of the MEP pathway in 1993, breaking the conventional concept that the MVA pathway is the only pathway to synthesize DMAPP and IPP (Rohmer et al. 1993). The enzymes and biochemistry of each step of the MEP pathway have been analyzed since that time (Fig. 3) (Grawert et al. 2011; Hunter 2007). Converting the central carbon intermediates pyruvate and glyceraldehyde-3-phosphate (G3P) to DMAPP or IPP requires eight reactions catalyzed by nine enzymes (Fig. 3). 1-Deoxy-d-xylulose-5-phosphate (DXP) is produced by DXP synthase (DXS), which catalyzes the condensation of pyruvate and G3P. DXP is converted into MEP by DXP reductoisomerase (DXR or IspC). MEP is transformed into 2C-methyl-d-erythritol-2,4-cyclo-diphosphate (MEC) by three sequential steps in which two intermediate products, 4-diphosphocytidyl-2C-methyl-d-erythritol (CDP-ME) and 4-diphosphocytidyl-2C-methyl-d-erythritol-2-phosphate (CDP-MEP), are produced. These three steps are catalyzed by CDP-ME cytidylyltransferase (IspD), CDP-ME kinase (IspE), and MEC synthase (IspF). MEC is converted to 4-hydroxy-3-methyl-2-(E)-butenyl-4-diphosphate (HMBPP) by HMBPP synthase (IspG). The production of IPP is catalyzed by HMBPP reductase (IspH). Isopentenyl-diphosphate isomerase (IDI) is responsible for the conversion between DMAPP and IPP.
Even though the process of the MEP pathway has been elucidated, the utilization of this pathway in E. coli has not resulted in high efficiency. All of the enzymes except IspS are natural enzymes; therefore, the problems in heterogeneous introduction would not be faced in the production of isoprene with an engineered MEP pathway in E. coli. Regulatory mechanisms at the transcriptional and translational levels should bring more attention to further research, which will have a significant impact on the microbial production of isoprenoids.
Restrictive points of the MEP pathway
To maximize the production of IPP and DMAPP for isoprene synthesis, a complete understanding of the regulatory mechanisms of the metabolic flux through the MEP pathway is of tremendous importance. It is proposed that the MEP pathway may have several potential control points, DXS, DXR, IspD, IspF, IspG, IspH, and IDI, with different enzymes exhibiting different degrees of control (Fig. 3). DXS has been shown to be a key rate-limiting enzyme in microbes and plants (Lois et al. 2000; Rodriguez-Concepcion and Boronat 2002). It is also feedback-regulated by the intermediates IPP and DMAPP, which bind with DXS and lead to its inactivation (Banerjee et al. 2013). DXR appears to be another rate-limiting enzyme (Rodríguez-Concepción 2006). A positive correlation between increased isoprenoid accumulation and the overexpression of DXR was found in peppermint (Mahmoud and Croteau 2001). The last two steps of the MEP pathway, catalyzed by IspG and IspH, are also considered to be regulatory nodes (Rodríguez-Concepción 2006). IspG and IspH contain a dioxygen-sensitive iron-sulfur [4Fe–4S] cluster that participates in the reduction process with the presence of a redox shuttle, such as flavodoxin/flavodoxin reductase/NADPH (Seemann et al. 2002; Wolff et al. 2003). Overexpression of IspG prevents the efflux of MEC, resulting in an increase of downstream isoprenoid production in E. coli (Zhou et al. 2012). In some species, the rate-limiting role of IspG parallels the release of upstream bottlenecks. Without the overexpression of DXS, increased carotenoid accumulation was not achieved by only the IspG up-regulation in E. coli (Flores-Perez et al. 2008). IDI has been proven to be another rate-limiting enzyme in isoprenoid production. A 1.4-fold increase in β-carotene production was achieved by introducing a strong promoter for IDI expression (Yuan et al. 2006). In a few studies, IspD and IspF were also rate-limiting enzymes. Combinational overexpression of IspD and IspF by replacing the wide promoter with a strong promoter led to increased β-carotene production (Yuan et al. 2006). However, IspD and IspF appear to be weaker bottlenecks, and they are often ignored in the metabolic engineering of isoprenoid production in common research. In engineered E. coli, DXS, DXR, and IDI are usually overexpressed to promote MEP pathway flux, with a resulting positive effect.
Metabolic engineering of the MEP pathway in E. coli
With the existence of several bottlenecks, the MEP pathway has been engineered to improve isoprene production. As strong bottlenecks, DXS and DXR are mostly engineered to promote metabolic flux. The classic engineering methods, overexpression of the native genes and introduction of genes from other organisms, are performed. In an engineered E. coli strain, recruitment of DXS and DXR from B. subtilis led to a 314 mg/L isoprene yield, which was 2-fold higher than the strain with native DXS and DXR overexpression (Zhao et al. 2011). Furthermore, to improve enzyme activity, directed co-evolution of DXS/DXR/IDI was applied, and improvement in isoprene production by 60% was achieved (Lv et al. 2016). Two other restrictive points, IspG and IspH, are also focused to further improve the metabolic flux. In an engineered E. coli strain, in which DXS, IDI, and IspS were overexpressed, MEC, the substrate of IspG, was observed to accumulate, and the metabolic flux was hindered. Three further approaches were applied to solve this problem. First, gcpE (encoding IspG) and lytB (encoding IspH) from Thermosynechococcus elongatus were introduced into E. coli, resulting in increased isoprene production (Chotani et al. 2013). Second, IscR, which encodes an enzyme responsible for repressing the expression of iron–sulfur [4Fe–4S]-containing genes, was deleted from the host (Akhtar and Jones 2008; Chotani et al. 2013). Third, the catalytic activity of IspG and IspH can be improved by flavodoxin and flavodoxin-NADP+ oxidoreductase. Overexpression of the reduction shuttle-related genes and endogenous fldA and introduction of PetF and PetH from T. elongatus led to improved enzyme activity and promoted metabolic flux in E. coli (Chotani et al. 2013). The MEP pathway has also been employed for isopentenol production by overexpressing endogenous IspG and DXS and exogenous expression of YhfR and NudF from B. subtilis in E. coli, with a total of 61.9 mg/L titer obtained by 5-L-scale batch cultivation (Liu et al. 2014).
For isoprene and isopentenol production, most researchers focus on the rate-limiting enzymes and perform common engineering methods, such as overexpression, direct evolution, and gene deletion, as described above, to improve enzyme expression or enzyme activity. As the MEP pathway was discovered only 20 years ago, the regulatory mechanisms and enzymes of this metabolic pathway are poorly studied. A better understanding of the MEP pathway is necessary, and further optimization strategies for isoprene and isopentenol production in E. coli need to be explored.
Introduction of the heterogeneous MVA pathway in E. coli
Description of the MVA pathway
The MVA pathway is an alternative pathway that is also utilized for isoprene and isopentenol production. The MVA pathway naturally operates in the cytoplasm of most eukaryotes, fungi, and plants, while the MEP pathway functions in many bacteria, algae, cyanobacteria, and plant chloroplasts. However, even though the MEP pathway is naturally operational in E. coli, research utilizing the MEP pathway for the production of isoprene or other isoprenoids is far less advanced than research introducing the whole MVA pathway. The MVA pathway was first discovered in the 1950s, 40 years earlier than the MEP pathway, and it has been better elucidated than the MEP pathway. The regulatory mechanisms and biochemistry of the MVA pathway are well characterized. Utilization of the MVA pathway for the industrial production of isoprenoids has been extensively performed, and great success has been obtained. Briefly, the MVA pathway is divided into two pathways, the upper pathway and the lower pathway (Fig. 3). The upper pathway includes three steps from acetyl-CoA to MVA, which are catalyzed by acetoacetyl-CoA thiolase (ACCT), 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) synthase (HMGS), and HMG-CoA reductase (HMGR) (Fig. 3). MVA is converted into IPP through the lower pathway via three reactions (Fig. 3). Mevalanote-5-phosphate (MVAP) is produced from MVA by mevalonate kinase (MK). MVAP is transformed into IPP through two different pathways. In eukaryotes, IPP is produced from MVAP through phosphorylation and decarboxylation steps, which are catalyzed by MVAP kinase (PMK) and MVAPP decarboxylase (MDD), respectively. However, in archaea, the decarboxylation occurs first, and MVAP is converted to IPP by two enzymes, MVAP decarboxylase (MPD) and isopentenyl phosphate (IP) kinase (IPK). IPP is subsequently converted into DMAPP through an isomerization reaction catalyzed by IDI. The structural and functional basis for every enzyme has been described in detail and was summarized by Miziorko (2011).
Restrictive points of the MVA pathway
Like the MEP pathway, metabolic flux through the MVA pathway is tightly regulated by several control nodes (Fig. 3). In the upper pathway, HMGR is proposed to be a key enzyme controlling the carbon flux in different species. In mammals, HMGR is a rate-limiting enzyme and the primary target of cholesterol-lowering drug therapy for sterol and cholesterol synthesis through MVA pathway (Burg and Espenshade 2011). In plants, an improvement in isoprenoid production has been detected after the overexpression of HMGR (Stermer et al. 1994). These studies indicate that HMGR plays an essential role in the metabolic flux through the MVA pathway, and optimization of this point is necessary. In contrast to HMGR, ACCT and HMGS appear to subtly regulate the carbon flux. Similarly, the lower MVA pathway is tightly hampered by several restrictive points. The first step, catalyzed by MK, is strongly influenced by feedback regulation at transcriptional and post-translational levels (Hinson et al. 1997). Even through MK is not naturally expressed in E. coli, it is tightly regulated by the metabolites of downstream pathways, namely, DMAPP, IPP, GPP, and FPP, as well as other isoprenoids in bacteria and eukaryotes. In another study, targeted proteomics analysis has also identified two potential bottlenecks, MK and MPK, in engineered E. coli (Redding-Johanson et al. 2011). IDI is identified as another rate-limiting point through the MVA pathway and has been described in the MEP pathway section. Even though the upper pathway is regulated by three points, when heterogeneously expressed in E. coli, the metabolic flux restriction can be solved by appropriate modification (described below). However, the restrictive points in the lower pathway are not easy to eliminate. Mevalonate accumulation is detected in most engineered E. coli hosts. Moreover, with IspS showing high Km and low kcat, IPP and DMAPP accumulate, regulating the expression of upstream genes in a feedback manner. The metabolic flux limitation in the lower MVA pathway is serious, and research on further regulation mechanisms is necessary.
Metabolic engineering of the MVA pathway in E. coli
As a pathway that does not naturally exist in E. coli, introduction of the whole pathway from other organisms and modification of the restrictive points are necessary for bio-isoprene and isopentenol production. MVA pathways from different organism sources have been implemented in E. coli through the approaches of genome integration or the introduction of independent plasmid constructs. MVA pathways from different organisms exhibit different enzyme efficiencies. A strain utilizing the upper pathway from Enterococcus faecalis showed a 5-fold increase in isoprene production compared with a strain utilizing the upper pathway from Saccharomyces cerevisiae (Yang et al. 2012a, b). Genome integration is a powerful approach to enhance stable gene expression in E. coli. In cyanobacteria, integration of the upper pathway from E. faecalis, lower pathway from Streptococcus pneumoniae, an additional AtoB from E. coli, and an IspS from kudzu into the chromosome have been applied for isoprene production (Bentley et al. 2014). This approach has not been applied in E. coli, and further improvement may result. As an alternative to whole pathway engineering, optimization of the rate-limiting enzymes (HMGS and MK) through the MVA pathway can also significantly improve isoprene production. Studies have indicated that the enzymatic reaction increased dramatically (140-fold) after alanine 110 of HMGS from E. faecalis (mvaS) was mutated to glycine; corresponding isoprene production increased 2.3-fold (Steussy et al. 2006; Yang et al. 2012a). Selection of MK from Methanosarcina mazei, a feedback-resistant enzyme, is often applied for isoprenoid production. A 5-fold increase in isoprene accumulation was achieved when an additional MK from M. mazei was expressed in E. coli (Beck et al. 2014). Furthermore, heterogeneous expression of the MVA pathway in E. coli is enhanced by choosing appropriate translation initiation regions (TIRs). In the engineered E. coli strain, the introduction of TIRs from E. coli upstream of each gene in the lower pathway from S. pneumoniae resulted in a 5-fold increase in isoprene production compared to the utilization of S. pneumoniae native TIRs (Zurbriggen et al. 2012).
Though engineering methods of the MVA pathway in E. coli have been implemented, metabolic flux of the pathway is still seriously limited, especially in the lower pathway. Accumulation of MVA is detected in most engineered E. coli hosts. Several approaches have been applied to circumvent this problem. To improve the consumption of MVA, a novel pathway that circumvents the rate-limiting steps has been applied (Yang et al. 2016b). In this novel pathway, MVA is catalyzed by fatty acid decarboxylase (OleTJE) to isoprenol, which is catalyzed by oleate hydratase (OhyAEM) to produce isoprene (Fig. 3). Although the productivity of this novel pathway is very low, screening for enzymes with better affinity and activity may be a promising solution. MDD, which shows promiscuous decarboxylase activity toward MVA and MVAP, was utilized for isoprenol production in another study (Kang et al. 2015). In novel pathway I, isoprenol is produced from MVA directly, catalyzed by MDD. In novel pathway II, MVAP is catalyzed by MDD to produce IP, which is dephosphorylated by phosphatase to produce isoprenol. Both novel pathways circumvent the toxic accumulation of IPP and DMAPP and show decreased ATP consumption. However, novel pathway II showed more isoprenol production than novel pathway I. In fact, novel pathway II is similar to the MVA pathway in archaea, in which MVAP is catalyzed by MPD to produce IP, which is phosphorylated by IPK to produce IPP (Fig. 3). Therefore, novel pathway II shows more potential for isoprenol production, and screening powerful enzymes capable of catalyzing MVAP to IP will be necessary in the future. As an alternative to cell factories, cell-free systems utilizing the MVA pathway have also been attempted. Our group has established a cell-free system in which five enzymes were utilized to produce isoprene from mevalonate, and the optimized enzyme ratio was analyzed, preventing the accumulation of intermediates (Cheng et al. 2017). In the last 2 years, several studies have been performed attempting to assess bio-isoprene production in other microorganisms with the introduction of the MVA pathway and IspS. Isoprene production has been successfully detected in engineered S. cerevisiae, Bacillus spp., cyanobacteria, and Clostridium ljungdahlii (Chaves et al. 2017; Diner et al. 2018; Gomaa et al. 2017; Wang et al. 2017). However, until now, the highest isoprene production was still obtained from engineered E. coli with the whole MVA pathway and IspS engineered. Utilization of these approaches, novel pathways, cell-free system, and other cell factories are still in the exploratory stage and need further research.
As an alternative to utilization of the MVA or MEP pathway alone, synergy between the two pathways was performed, resulting in approximately 20-fold and 3-fold increases relative to strains with only an engineered MEP or MVA pathway, respectively (Yang et al. 2016a). In this strain, the restrictive points of the MEP pathway and the whole MVA pathway were engineered. However, the communication between MEP and MVA pathway is complicated, and engineering of both of the pathways separately in the same strain is not sufficient. In recent research, when only the MVA pathway was introduced into an E. coli host, the intermediate product of the MEP pathway, MEC, accumulated substantially, which indicated that the native MEP pathway flux was seriously influenced when the MVA pathway was introduced (George et al. 2018). More information on the connection between these two pathways may be deciphered in the near future and will be helpful for isoprene production engineering of E. coli hosts.
Although the MEP and MVA pathways have been widely applied for isoprene production, large differences in production have resulted. Strains utilizing the native MEP pathway have lower isoprene production than strains engineered by introducing the heterogeneous MVA pathway. Theoretically, both pathways have their respective pros and cons, as reviewed by Cao et al. (2018). The MEP pathway shows a higher theoretical yield, and the MVA pathway is more energetically friendly. It is speculated that the NAD(P)H and ATP consumption levels of the MEP pathway are a heavy burden for isoprene production. Furthermore, the native MEP pathway is strictly regulated by the cell system. The regulatory mechanism in E. coli may counteract the flux promotion via the overexpression of key points, DXS and DXR. In contrast, the exogenous MVA pathway acts more aggressively, without the corresponding regulation. Of course, accumulation of intermediates of the MVA pathway is also detected, which explains the decreased cell density when the MVA pathway is introduced.
Optimization of precursor support
A large number of studies are highly focused on optimization of the MEP or the MVA pathway to improve isoprene production. However, sufficient support of the precursors, G3P and pyruvate in the MEP pathway and acetyl-CoA in the MVA pathway, also plays essential roles.
When the MVA pathway is utilized, marked improvement of the accumulation of the precursor acetyl-CoA is essential for high-level production. Phosphoketolase (pkl), which catalyzes the direct conversion of xylulose-5-phosphate or fructose-5-phosphate into acetyl-CoA without carbon loss, allows for the production of three acetyl-CoAs per glucose. Overexpression of pkl from Enterococcus gallinarum resulted in higher utilization efficiency of glucose and higher cumulative isoprene yield (Fig. 4) (Beck et al. 2015). Isoprene production can also be enhanced by overexpression of pgl, encoding a 6-phosphogluconolactonase, which improves flux through the PPP and suppresses the glycosylation of heterogeneous enzymes, providing enough acetyl-CoA for the MVA pathway (Fig. 4) (Beck et al. 2013b; Cervin et al. 2012). In E. coli, acetyl-CoA is involved in several pathways. Impeding the pathways for byproduct formation from precursor acetyl-CoA is a powerful method for improving isoprene production (Fig. 4). In an engineered E. coli strain, knockout genes related to byproducts such as lactate, acetate, and ethanol formation led to improved isoprene production, reaching 1832 mg/L, the highest among all of the publications (Fig. 4) (Kim et al. 2016). Precursors of the MEP and MVA pathways are involved in numerous essential pathways that are essential for organism growth. Overexpression or deletion of particular genes may have complicated effects on the engineered strain. Therefore, studies on the engineering of precursor support are scarce.
Considering production costs, appropriate support of carbon sources is very important for the production of isoprene and other isoprenoids in industry. Several carbon sources, such as corn stover, bagasse, softwood pulp, and glucose, have been tested, and softwood pulp produced the highest amount of isoprene, slightly less than the amount produced by glucose (Cervin et al. 2012). Isoprene production was also detected in the engineered strain, which consumed fatty acids or palm oil (Cervin et al. 2012). Conversion of glycerol to isoprene was achieved in E. coli by recruiting the MVA pathway and isoprene synthase through overexpression of glpK and glpD, which promotes glycerol dissimilation (Bredow et al. 2015). Glycerol was found to be superior to glucose as a carbon source for isoprenoid production. In one study, glycerol yielded the highest β-carotene production and cell growth among the various carbon sources tested (Yoon et al. 2009). In another study, using glycerol as the major carbon source and glucose and l-arabinose as auxiliary carbon sources improved lycopene production (Kim et al. 2011). When the carbon source was galactose, the De Ley–Doudoroff (DD) pathway was selected, which produces equivalent amounts of G3P and pyruvate (Ramos et al. 2014).
Conclusion and prospects
Isoprene is an essential platform chemical in industrial applications, especially in rubber synthesis. Microbial isoprene production has been studied for the past 18 years to address the multiple negative influences of petroleum consumption, as petroleum is the original source of not only isoprene but also many other organic chemicals important to industry. E. coli, which is perhaps the most technically mature host for genetic manipulation and heterologous expression, is widely chosen for isoprene production to introduce the whole heterologous MVA pathway or modify the inherent MEP pathway and heterologously express isoprene synthetase from plants. A few limitation points of the metabolic flux have been identified, and optimization of the key enzymes with approaches such as protein engineering and large-scale screening has been implemented. However, even though high isoprene production has been achieved, there is still much room for improvement. Multiple steps are needed for isoprene production from its common precursors, and monitoring every step can help modulate enzyme expression, facilitating smooth carbon flux. In addition, multiple steps mean greater consumption of resources, and the exploration of novel metabolic pathways is a promising approach for isoprene production. In recent years, many other hosts aside from E. coli and S. cerevisiae have been well characterized and utilized for chemical production. Though other producers, such as cyanobacteria, Bacillus spp., and Clostridium ljungdahlii, have been engineered, E. coli still exhibits unique advantages, including isoprene yield, its technical maturity as a host for genetic manipulation, and heterologous expression.
Microbial isopentenol production has been applied in the last 10 years. The enzyme responsible for isopentenol production from IPP and DMAPP has been identified. However, improvements in isopentenol production have been restricted by the low activity of this enzyme. Screening powerful enzymes may be a feasible improvement strategy. Recently, inspiring results have been achieved by building a truncated MVA pathway, and further improvements in isopentenol productivity are promising.
This study was supported by the National Natural Science Foundation of China (NSF No. 31400084), Hainan’s Key Project of Research and Development Plan (No. ZDYF2017155), the Taishan Scholars Climbing Program of Shandong (No. TSPD20150210), and the Youth Innovation Promotion Association (CAS No. 2017252).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Beck ZQ AR, Miller MC, Nielsen AT, Vaviline DV (2014) Increased isoprene producing using the archaeal lower mevalonate pathway. WO2010031062A1Google Scholar
- Beck ZQ, Bott RR, Rife CL, Wells DH, Miller JV (2013a) Three-dimensional structure of isoprene synthase and its use thereof for generating variants. US8518686B2Google Scholar
- Beck ZQ, Cervin MA, Nielsen AT, Peres CM (2013b) Compositions and methods of PGL for the increased production of isoprene. US8455236B2Google Scholar
- Beck ZQ, Eliot AC, Peres CM, Vaviline DV (2015) Utilization of phosphoketolase in the production of mevalonate, isoprenoid precursors, and isoprene. US8993305B2Google Scholar
- Bott RR, Cervin MA, Kellis Jr JT, McAuliffe JC, Miasnikov A, Peres CM, Rife CL, Wells DH, Weyler W, Whited GM (2014) Isoprene synthase variants for improved microbial production of isoprene. US8916370B2Google Scholar
- Bredow S, Doneske S, Li M, Zhou H, Monticello DJ, Campbell P (2015) Microorganisms and processes for the conversion of glycerol to isoprene. US2015/0225726A1Google Scholar
- Cervin MA, Chotani GK, Feher FJ, La Duca R, McAuliffe JC, Miasnikov A, Peres CM, Puhala AS, Sanford KJ, Valle F (2012) Compositions and methods for producing isoprene. US8288148B2Google Scholar
- Chotani GK, McAuliffe JC, Miller MC, Vaviline DV, Weyler W (2013) Isoprene production using the DXP and MVA pathway. US8507235B2Google Scholar
- Diner BA, Fan J, Scotcher MC, Wells DH, Whited GM (2018) Synthesis of heterologous mevalonic acid pathway enzymes in Clostridium ljungdahlii for the conversion of fructose and of syngas to mevalonate and isoprene. Appl Environ Microbiol 84(1):e01723–e01717. https://doi.org/10.1128/aem.01723-17 CrossRefPubMedGoogle Scholar
- Flores-Perez U, Perez-Gil J, Rodriguez-Villalon A, Gil M, Vera P, Rodriguez-Concepcion M (2008) Contribution of hydroxymethylbutenyl diphosphate synthase to carotenoid biosynthesis in bacteria and plants. Biochem Biophys Res Commun 371(3):510–514. https://doi.org/10.1016/j.bbrc.2008.04.115 CrossRefPubMedGoogle Scholar
- George KW, Thompson MG, Kim J, Baidoo EEK, Wang G, Benites VT, Petzold CJ, Chan LJG, Yilmaz S, Turhanen P, Adams PD, Keasling JD, Lee TS (2018) Integrated analysis of isopentenyl pyrophosphate (IPP) toxicity in isoprenoid-producing Escherichia coli. Metab Eng 47:60–72. https://doi.org/10.1016/j.ymben.2018.03.004 CrossRefPubMedGoogle Scholar
- Gomaa L, Loscar ME, Zein HS, Abdel-Ghaffar N, Abdelhadi AA, Abdelaal AS, Abdallah NA (2017) Boosting isoprene production via heterologous expression of the kudzu isoprene synthase gene (kIspS) into Bacillus spp. cell factory. AMB Express 7(1):161. https://doi.org/10.1186/s13568-017-0461-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Grawert T, Kaiser J, Zepeck F, Laupitz R, Hecht S, Amslinger S, Schramek N, Schleicher E, Weber S, Haslbeck M, Buchner J, Rieder C, Arigoni D, Bacher A, Eisenreich W, Rohdich F (2004) IspH protein of Escherichia coli: studies on iron–sulfur cluster implementation and catalysis. J Am Chem Soc 126(40):12847–12855. https://doi.org/10.1021/ja0471727 CrossRefPubMedGoogle Scholar
- Hayashi Y, Harada M, Takaoka S, Fukushima Y, Yokoyama K, Nishio Y, Tajima Y, Mihara Y, Nakata K, Tayima Y, Hayashi YA, Fukushima YA, Nakada K (2013) New polynucleotide useful for producing isoprene monomer, composition specific base pair sequence. US8962296-B2Google Scholar
- Kim JH, Wang C, Jang HJ, Cha MS, Park JE, Jo SY, Choi ES, Kim SW (2016) Isoprene production by Escherichia coli through the exogenous mevalonate pathway with reduced formation of fermentation byproducts. Microb Cell Factories 15(1):214. https://doi.org/10.1186/s12934-016-0612-6 CrossRefGoogle Scholar
- Liu H, Sun Y, Ramos KR, Nisola GM, Valdehuesa KN, Lee WK, Park SJ, Chung WJ (2013) Combination of Entner–Doudoroff pathway with MEP increases isoprene production in engineered Escherichia coli. PLoS One 8(12):e83290. https://doi.org/10.1371/journal.pone.0083290 CrossRefPubMedPubMedCentralGoogle Scholar
- Oku H, Inafuku M, Ishikawa T, Takamine T, Ishmael M, Fukuta M (2015) Molecular cloning and biochemical characterization of isoprene synthases from the tropical trees Ficus virgata, Ficus septica, and Casuarina equisetifolia. J Plant Res 128(5):849–861. https://doi.org/10.1007/s10265-015-0740-9 CrossRefPubMedGoogle Scholar
- Redding-Johanson AM, Batth TS, Chan R, Krupa R, Szmidt HL, Adams PD, Keasling JD, Lee TS, Mukhopadhyay A, Petzold CJ (2011) Targeted proteomics for metabolic pathway optimization: application to terpene production. Metab Eng 13(2):194–203. https://doi.org/10.1016/j.ymben.2010.12.005 CrossRefPubMedGoogle Scholar
- Sasaki K, Ohara K, Yazaki K (2005) Gene expression and characterization of isoprene synthase from Populus alba. FEBS Lett 579(11):2514–2518. https://doi.org/10.1016/j.febslet.2005.03.066
- Schnitzler JP, Arenz R, Steinbrecher R, Lehning A (1996) Characterization of an isoprene synthase from leaves of Quercus petraea (Mattuschka) Liebl. Bot Acta 109(3):216–221. https://doi.org/10.1111/j.1438-8677.1996.tb00566.x CrossRefGoogle Scholar
- Seemann M, Bui BTS, Wolff M, Tritsch D, Campos N, Boronat A, Marquet A, Rohmer M (2002) Isoprenoid biosynthesis through the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate synthase (GcpE) is a [4Fe–4S] protein. Angew Chem Int Ed 41(22):4337–4339. https://doi.org/10.1016/S0040-4039(01)02269-9 CrossRefGoogle Scholar
- Wang F, Lv X, Xie W, Zhou P, Zhu Y, Yao Z, Yang C, Yang X, Ye L, Yu H (2017) Combining Gal4p-mediated expression enhancement and directed evolution of isoprene synthase to improve isoprene production in Saccharomyces cerevisiae. Metab Eng 39:257–266. https://doi.org/10.1016/j.ymben.2016.12.011 CrossRefPubMedGoogle Scholar
- Whited GM, Feher FJ, Benko DA, Cervin MA, Chotani GK, McAuliffe JC, LaDuca RJ, Ben-Shoshan EA, Sanford KJ (2010) Technology update: development of a gas-phase bioprocess for isoprene-monomer production using metabolic pathway engineering. Ind Biotechnol 6(3):152–163. https://doi.org/10.1089/ind.2010.6.152 CrossRefGoogle Scholar
- Withers ST, Gottlieb SS, Lieu B, Newman JD, Keasling JD (2007) Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol 73(19):6277–6283. https://doi.org/10.1128/AEM.00861-07 CrossRefPubMedPubMedCentralGoogle Scholar
- Wolff M, Seemann M, Tse Sum Bui B, Frapart Y, Tritsch D, Estrabot AG, Rodríguez-Concepción M, Boronat A, Marquet A, Rohmer M (2003) Isoprenoid biosynthesis via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut-2-enyl diphosphate reductase (LytB/IspH) from Escherichia coli is a [4Fe–4S] protein. FEBS Lett 541(1–3):115–120. https://doi.org/10.1016/s0014-5793(03)00317-x CrossRefPubMedGoogle Scholar
- Zheng Y, Liu Q, Li L, Qin W, Yang J, Zhang H, Jiang X, Cheng T, Liu W, Xu X, Xian M (2013) Metabolic engineering of Escherichia coli for high-specificity production of isoprenol and prenol as next generation of biofuels. Biotechnol Biofuels 6:57. https://doi.org/10.1186/1754-6834-6-57 CrossRefPubMedPubMedCentralGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.